ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998

New Coalition To Lobby for Prevention

November 24, 1978

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

NCCS Networker Volume 11 Issue 2, Summer 1997

June 13, 1997